Literature DB >> 16533951

Counterregulatory deficits occur within 24 h of a single hypoglycemic episode in conscious, unrestrained, chronically cannulated mice.

Lauren Jacobson1, Tasneem Ansari, Owen P McGuinness.   

Abstract

Hypoglycemia-induced counterregulatory failure is a dangerous complication of insulin use in diabetes mellitus. Controlled hypoglycemia studies in gene knockout models, which require the use of mice, would aid in identifying causes of defective counterregulation. Because stress can influence counterregulatory hormones and glucose homeostasis, we developed glucose clamps with remote blood sampling in conscious, unrestrained mice. Male C57BL/6 mice implanted with indwelling carotid artery and jugular vein catheters were subjected to 2 h of hyperinsulinemic glucose clamps 24 h apart, with a 6-h fast before each clamp. On day 1, blood glucose was maintained (euglycemia, 178 +/- 4 mg/dl) or decreased to 62 +/- 1 mg/dl (hypoglycemia) by insulin (20 mU x kg(-1) x min(-1)) and variable glucose infusion. Donor blood was continuously infused to replace blood sample volume. Baseline plasma epinephrine (32 +/- 8 pg/ml), corticosterone (16.1 +/- 1.8 microg/dl), and glucagon (35 +/- 3 pg/ml) were unchanged during euglycemia but increased significantly during hypoglycemia, with a glycemic threshold of approximately 80 mg/dl. On day 2, all mice underwent a hypoglycemic clamp (blood glucose, 64 +/- 1 mg/dl). Compared with mice that were euglycemic on day 1, previously hypoglycemic mice had significantly higher glucose requirements and significantly lower plasma glucagon and corticosterone (n = 6/group) on day 2. Epinephrine tended to decrease, although not significantly, in repeatedly hypoglycemic mice. Pre- and post-clamp insulin levels were similar between groups. We conclude that counterregulatory responses to acute and repeated hypoglycemia in unrestrained, chronically cannulated mice reproduce aspects of counterregulation in humans, and that repeated hypoglycemia in mice is a useful model of counterregulatory failure.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16533951      PMCID: PMC1414786          DOI: 10.1152/ajpendo.00383.2005

Source DB:  PubMed          Journal:  Am J Physiol Endocrinol Metab        ISSN: 0193-1849            Impact factor:   4.310


  45 in total

1.  Intermittent hypoglycemia impairs glucose counterregulation.

Authors:  B Widom; D C Simonson
Journal:  Diabetes       Date:  1992-12       Impact factor: 9.461

2.  Effect of hyperketonemia and hyperlacticacidemia on symptoms, cognitive dysfunction, and counterregulatory hormone responses during hypoglycemia in normal humans.

Authors:  T Veneman; A Mitrakou; M Mokan; P Cryer; J Gerich
Journal:  Diabetes       Date:  1994-11       Impact factor: 9.461

3.  Counterregulatory adaptation to recurrent hypoglycemia in normal humans.

Authors:  M R Davis; H Shamoon
Journal:  J Clin Endocrinol Metab       Date:  1991-11       Impact factor: 5.958

4.  Resistance of growth hormone secretion to hypoglycemia in the mouse.

Authors:  M Tamaki; M Sato; M Niimi; J Takahara
Journal:  J Neuroendocrinol       Date:  1995-05       Impact factor: 3.627

5.  Impaired hormonal responses to hypoglycemia in spontaneously diabetic and recurrently hypoglycemic rats. Reversibility and stimulus specificity of the deficits.

Authors:  A M Powell; R S Sherwin; G I Shulman
Journal:  J Clin Invest       Date:  1993-12       Impact factor: 14.808

Review 6.  Stress and diabetes mellitus.

Authors:  R S Surwit; M S Schneider; M N Feinglos
Journal:  Diabetes Care       Date:  1992-10       Impact factor: 19.112

7.  Inhibitory effect of pregnancy on counterregulatory hormone responses to hypoglycemia in awake rat.

Authors:  G Rossi; P Lapaczewski; M P Diamond; R J Jacob; G I Shulman; R S Sherwin
Journal:  Diabetes       Date:  1993-10       Impact factor: 9.461

8.  Relative roles of insulin and hypoglycaemia on induction of neuroendocrine responses to, symptoms of, and deterioration of cognitive function in hypoglycaemia in male and female humans.

Authors:  C Fanelli; S Pampanelli; L Epifano; A M Rambotti; M Ciofetta; F Modarelli; A Di Vincenzo; B Annibale; M Lepore; C Lalli
Journal:  Diabetologia       Date:  1994-08       Impact factor: 10.122

9.  Reduced neuroendocrine and symptomatic responses to subsequent hypoglycemia after 1 episode of hypoglycemia in nondiabetic humans.

Authors:  S R Heller; P E Cryer
Journal:  Diabetes       Date:  1991-02       Impact factor: 9.461

10.  Evidence against important catecholamine compensation for absent glucagon counterregulation.

Authors:  P De Feo; G Perriello; E Torlone; C Fanelli; M M Ventura; F Santeusanio; P Brunetti; J E Gerich; G B Bolli
Journal:  Am J Physiol       Date:  1991-02
View more
  26 in total

Review 1.  Secrets of the lac operon. Glucose hysteresis as a mechanism in dietary restriction, aging and disease.

Authors:  Charles V Mobbs; Jason W Mastaitis; Minhua Zhang; Fumiko Isoda; Hui Cheng; Kelvin Yen
Journal:  Interdiscip Top Gerontol       Date:  2007

2.  Study of In Vivo Glucose Metabolism in High-fat Diet-fed Mice Using Oral Glucose Tolerance Test (OGTT) and Insulin Tolerance Test (ITT).

Authors:  Csörsz Nagy; Elisa Einwallner
Journal:  J Vis Exp       Date:  2018-01-07       Impact factor: 1.355

Review 3.  Hypoglycemia unawareness prevention: Targeting glucagon production.

Authors:  Willis K Samson; Lauren M Stein; Mollisa Elrick; Alison Salvatori; Grant Kolar; John A Corbett; Gina L C Yosten
Journal:  Physiol Behav       Date:  2016-04-11

Review 4.  In-depth metabolic phenotyping of genetically engineered mouse models in obesity and diabetes.

Authors:  Hui-Young Lee; Kyeong-Hoon Jeong; Cheol Soo Choi
Journal:  Mamm Genome       Date:  2014-05-03       Impact factor: 2.957

5.  Brain glycogen supercompensation in the mouse after recovery from insulin-induced hypoglycemia.

Authors:  Sarah E Canada; Staci A Weaver; Shannon N Sharpe; Bartholomew A Pederson
Journal:  J Neurosci Res       Date:  2011-01-21       Impact factor: 4.164

6.  Hypothalamic ventromedial COUP-TFII protects against hypoglycemia-associated autonomic failure.

Authors:  Lina Sabra-Makke; Micol Maritan; Julien Planchais; Marie Boutant; Jean-Paul Pégorier; Patrick C Even; Mireille Vasseur-Cognet; Pascale Bossard
Journal:  Proc Natl Acad Sci U S A       Date:  2013-02-25       Impact factor: 11.205

7.  Insulin signaling in alpha cells modulates glucagon secretion in vivo.

Authors:  Dan Kawamori; Amarnath J Kurpad; Jiang Hu; Chong Wee Liew; Judy L Shih; Eric L Ford; Pedro L Herrera; Kenneth S Polonsky; Owen P McGuinness; Rohit N Kulkarni
Journal:  Cell Metab       Date:  2009-04       Impact factor: 27.287

8.  Development of autonomic dysfunction with intermittent hypoxia in a lean murine model.

Authors:  P Chalacheva; J Thum; T Yokoe; C P O'Donnell; M C K Khoo
Journal:  Respir Physiol Neurobiol       Date:  2013-06-14       Impact factor: 1.931

Review 9.  NIH experiment in centralized mouse phenotyping: the Vanderbilt experience and recommendations for evaluating glucose homeostasis in the mouse.

Authors:  Owen P McGuinness; Julio E Ayala; Maren R Laughlin; David H Wasserman
Journal:  Am J Physiol Endocrinol Metab       Date:  2009-07-28       Impact factor: 4.310

10.  Neuronostatin acts via GPR107 to increase cAMP-independent PKA phosphorylation and proglucagon mRNA accumulation in pancreatic α-cells.

Authors:  Mollisa M Elrick; Willis K Samson; John A Corbett; Alison S Salvatori; Lauren M Stein; Grant R Kolar; Aaron Naatz; Gina L C Yosten
Journal:  Am J Physiol Regul Integr Comp Physiol       Date:  2015-11-11       Impact factor: 3.619

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.